{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:30Z","timestamp":1791288930906,"version":"4.3.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T00:00:00Z","timestamp":1327017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T00:00:00Z","timestamp":1327017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Cartilage oligomeric matrix protein (COMP) is found at elevated concentrations in sera of patients with joint diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA). We recently showed that COMP activates complement via the alternative pathway and that COMP-C3b complexes are present in sera of RA patients, but not in healthy controls. We now set out to elaborate on the information provided by this marker in a variety of diseases and larger patient cohorts.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>COMP-C3b levels in sera were measured by using an enzyme-linked immunosorbent assay (ELISA) capturing COMP and detecting C3b. Serum COMP was measured by using ELISA.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>COMP-C3b levels were significantly elevated in patients with RA as well as in systemic lupus erythematosus (SLE), compared with healthy controls. SLE patients with arthritis had significantly higher COMP-C3b levels than did those without. COMP-C3b was furthermore elevated in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA), reactive arthritis, systemic sclerosis, and OA. COMP-C3b did not correlate with COMP in any of the patient groups. COMP-C3b correlated with disease activity in RA, but not in other diseases. COMP-C3b levels in RA patients decreased on treatment with tumor necrosis factor (TNF)-\u03b1 inhibitors, whereas the levels increased in patients with AS or PsA. The changes of COMP-C3b did not parallel the changes of C-reactive protein (CRP).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>COMP-C3b levels are elevated in several rheumatologic diseases and correlate with inflammatory measures in RA. COMP-C3b levels in RA decrease during TNF-\u03b1 inhibition differently from those of CRP, suggesting that formation of COMP-C3b relates to disease features not reflected by general inflammation measures.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3694","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T19:39:19Z","timestamp":1327088359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-\u03b1 treatment"],"prefix":"10.1186","volume":"14","author":[{"given":"Kaisa E","family":"Happonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Saxne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Geborek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders A","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hesselstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Heineg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,20]]},"reference":[{"key":"3440_CR1","volume-title":"Biomarkers for Cartilage and Bone in Rheumatoid Arthritis","author":"T Saxne","year":"2006","unstructured":"Saxne T, M\u00e5nsson B, Heineg\u00e5rd D: Biomarkers for Cartilage and Bone in Rheumatoid Arthritis. 2006, Oxford: Oxford University Press, 2","edition":"2"},{"key":"3440_CR2","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1136\/ard.2007.082099","volume":"67","author":"R Hesselstrand","year":"2008","unstructured":"Hesselstrand R, Kassner A, Heineg\u00e5rd D, Saxne T: COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker. Ann Rheum Dis. 2008, 67: 1242-8.","journal-title":"Ann Rheum Dis"},{"key":"3440_CR3","doi-asserted-by":"crossref","first-page":"22346","DOI":"10.1016\/S0021-9258(18)41677-8","volume":"267","author":"A Oldberg","year":"1992","unstructured":"Oldberg A, Antonsson P, Lindblom K, Heineg\u00e5rd D: COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem. 1992, 267: 22346-50.","journal-title":"J Biol Chem"},{"key":"3440_CR4","doi-asserted-by":"publisher","first-page":"20397","DOI":"10.1074\/jbc.273.32.20397","volume":"273","author":"K Rosenberg","year":"1998","unstructured":"Rosenberg K, Olsson H, M\u00f6rgelin M, Heineg\u00e5rd D: Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem. 1998, 273: 20397-403. 10.1074\/jbc.273.32.20397.","journal-title":"J Biol Chem"},{"key":"3440_CR5","doi-asserted-by":"publisher","first-page":"31166","DOI":"10.1074\/jbc.M705735200","volume":"282","author":"K Halasz","year":"2007","unstructured":"Halasz K, Kassner A, M\u00f6rgelin M, Heineg\u00e5rd D: COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem. 2007, 282: 31166-73. 10.1074\/jbc.M705735200.","journal-title":"J Biol Chem"},{"key":"3440_CR6","doi-asserted-by":"publisher","first-page":"25294","DOI":"10.1074\/jbc.M403778200","volume":"279","author":"HH Mann","year":"2004","unstructured":"Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R: Interactions between the cartilage oligomeric matrix protein and matrilins: implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem. 2004, 279: 25294-8. 10.1074\/jbc.M403778200.","journal-title":"J Biol Chem"},{"key":"3440_CR7","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1002\/art.27720","volume":"62","author":"KE Happonen","year":"2010","unstructured":"Happonen KE, Saxne T, Aspberg A, M\u00f6rgelin M, Heineg\u00e5rd D, Blom AM: Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum. 2010, 62: 3574-83. 10.1002\/art.27720.","journal-title":"Arthritis Rheum"},{"key":"3440_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/eji.200424895","volume":"34","author":"MA Hietala","year":"2004","unstructured":"Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl R, Pekna M: Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol. 2004, 34: 1208-16. 10.1002\/eji.200424895.","journal-title":"Eur J Immunol"},{"key":"3440_CR9","doi-asserted-by":"publisher","first-page":"e13511","DOI":"10.1371\/journal.pone.0013511","volume":"5","author":"KS Nandakumar","year":"2010","unstructured":"Nandakumar KS, Jansson A, Xu B, Rydell N, Blom AM, Holmdahl R: A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis. PloS One. 2010, 5: e13511-10.1371\/journal.pone.0013511.","journal-title":"PloS One"},{"key":"3440_CR10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/art.21729","volume":"54","author":"D Wouters","year":"2006","unstructured":"Wouters D, Voskuyl AE, Molenaar ET, Dijkmans BA, Hack CE: Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. Arthritis Rheum. 2006, 54: 1143-50. 10.1002\/art.21729.","journal-title":"Arthritis Rheum"},{"key":"3440_CR11","first-page":"473","volume":"73","author":"BP Morgan","year":"1988","unstructured":"Morgan BP, Daniels RH, Williams BD: Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol. 1988, 73: 473-8.","journal-title":"Clin Exp Immunol"},{"key":"3440_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.49.10.747","volume":"49","author":"PJ Jose","year":"1990","unstructured":"Jose PJ, Moss IK, Maini RN, Williams TJ: Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis. 1990, 49: 747-52. 10.1136\/ard.49.10.747.","journal-title":"Ann Rheum Dis"},{"key":"3440_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1172\/JCI107949","volume":"55","author":"K Tanimoto","year":"1975","unstructured":"Tanimoto K, Cooper NR, Johnson JS, Vaughan JH: Complement fixation by rheumatoid factor. J Clin Invest. 1975, 55: 437-45. 10.1172\/JCI107949.","journal-title":"J Clin Invest"},{"key":"3440_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/ard.52.11.795","volume":"52","author":"Y Sato","year":"1993","unstructured":"Sato Y, Sato R, Watanabe H, Kogure A, Watanabe K, Nishimaki T, Kasukawa R, Kuraya M, Fujita T: Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors. Ann Rheum Dis. 1993, 52: 795-800. 10.1136\/ard.52.11.795.","journal-title":"Ann Rheum Dis"},{"key":"3440_CR15","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/art.24622","volume":"60","author":"LA Trouw","year":"2009","unstructured":"Trouw LA, Haisma EM, Levarht EW, van der Woude D, Ioan-Facsinay A, Daha MR, Huizinga TW, Toes RE: Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009, 60: 1923-31. 10.1002\/art.24622.","journal-title":"Arthritis Rheum"},{"key":"3440_CR16","doi-asserted-by":"publisher","first-page":"32301","DOI":"10.1074\/jbc.M504828200","volume":"280","author":"A Sj\u00f6berg","year":"2005","unstructured":"Sj\u00f6berg A, \u00d6nnerfjord P, M\u00f6rgelin M, Heineg\u00e5rd D, Blom AM: The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005, 280: 32301-8. 10.1074\/jbc.M504828200.","journal-title":"J Biol Chem"},{"key":"3440_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.molimm.2008.09.018","volume":"46","author":"AP Sj\u00f6berg","year":"2009","unstructured":"Sj\u00f6berg AP, Manderson GA, M\u00f6rgelin M, Day AJ, Heineg\u00e5rd D, Blom AM: Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol. 2009, 46: 830-9. 10.1016\/j.molimm.2008.09.018.","journal-title":"Mol Immunol"},{"key":"3440_CR18","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","volume":"32","author":"AJ Nauta","year":"2002","unstructured":"Nauta AJ, Trouw LA, Daha MR, Tijsma O, Nieuwland R, Schwaeble WJ, Gingras AR, Mantovani A, Hack EC, Roos A: Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol. 2002, 32: 1726-36. 10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R.","journal-title":"Eur J Immunol"},{"key":"3440_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-24. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"3440_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2474-7-98","volume":"7","author":"ML Andersson","year":"2006","unstructured":"Andersson ML, Thorstensson CA, Roos EM, Petersson IF, Heineg\u00e5rd D, Saxne T: Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. BMC Musculoskeletal Disord. 2006, 7: 98-10.1186\/1471-2474-7-98.","journal-title":"BMC Musculoskeletal Disord"},{"key":"3440_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"25","author":"AT Masi","year":"1980","unstructured":"Masi AT, Rodnan GP, Medsger TA, Altman RD: Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980, 25: 581-90.","journal-title":"Arthritis Rheum"},{"key":"3440_CR22","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15: 202-5.","journal-title":"J Rheumatol"},{"key":"3440_CR23","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D, Wigley F, Medsger TA, Steen V, Moreland L, Dixon M, Massa M, Lally E, McCloskey D, Varga J, Ingenito F, Furst D: Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995, 22: 1281-5.","journal-title":"J Rheumatol"},{"key":"3440_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-7. 10.1002\/art.1780251101.","journal-title":"Arthritis Rheum"},{"key":"3440_CR25","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB: Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002, 29: 288-91.","journal-title":"J Rheumatol"},{"key":"3440_CR26","doi-asserted-by":"publisher","first-page":"R181","DOI":"10.1186\/ar760","volume":"5","author":"M Crnkic","year":"2003","unstructured":"Crnkic M, M\u00e5nsson B, Larsson L, Geborek P, Heineg\u00e5rd D, Saxne T: Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther. 2003, 5: R181-5. 10.1186\/ar760.","journal-title":"Arthritis Res Ther"},{"key":"3440_CR27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F","volume":"44","author":"JP Pelletier","year":"2001","unstructured":"Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001, 44: 1237-47. 10.1002\/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F.","journal-title":"Arthritis Rheum"},{"key":"3440_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/rheumatology\/keg214","volume":"42","author":"T Saxne","year":"2003","unstructured":"Saxne T, Lindell M, M\u00e5nsson B, Petersson IF, Heineg\u00e5rd D: Inflammation is a feature of the disease process in early knee joint osteoarthritis. Rheumatology (Oxford, England). 2003, 42: 903-4. 10.1093\/rheumatology\/keg186.","journal-title":"Rheumatology (Oxford, England)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3694\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:26:27Z","timestamp":1728383187000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,20]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2]]}},"alternative-id":["3440"],"URL":"https:\/\/doi.org\/10.1186\/ar3694","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,20]]},"assertion":[{"value":"3 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R15"}}